Advertisement
Advertisement

ICUI

ICUI logo

ICU Medical Inc

154.06
USD
Sponsored
+4.43
+2.96%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

154.02

-0.04
-0.03%

ICUI Earnings Reports

Positive Surprise Ratio

ICUI beat 35 of 39 last estimates.

90%

Next Report

Date of Next Report
Feb 19, 2026
Estimate for Q4 25 (Revenue/ EPS)
$542.44M
/
$1.72
Implied change from Q3 25 (Revenue/ EPS)
+1.01%
/
-14.85%
Implied change from Q4 24 (Revenue/ EPS)
-12.74%
/
-18.48%

ICU Medical Inc earnings per share and revenue

On Nov 06, 2025, ICUI reported earnings of 2.02 USD per share (EPS) for Q3 25, beating the estimate of 1.46 USD, resulting in a 38.85% surprise. Revenue reached 536.99 million, compared to an expected 520.65 million, with a 3.14% difference. The market reacted with a +8.09% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of 1.72 USD, with revenue projected to reach 542.44 million USD, implying an decrease of -14.85% EPS, and increase of 1.01% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
logo
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
logo
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
logo
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
logo
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
logo
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
logo
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
logo
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
logo
Canopy Growth Corporation Common Shares
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.13
Surprise
-198.00%
logo
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
FAQ
For Q3 2025, ICU Medical Inc reported EPS of $2.02, beating estimates by 38.85%, and revenue of $536.99M, 3.14% above expectations.
The stock price moved up 8.09%, changed from $129.67 before the earnings release to $140.16 the day after.
The next earning report is scheduled for Feb 19, 2026.
Based on 8 analysts, ICU Medical Inc is expected to report EPS of $1.72 and revenue of $542.44M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement